Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
16.37
+0.08 (0.49%)
Sep 1, 2026, 4:00 PM EDT - Market closed

Carlsmed Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Income
-36.35-29.63-24.26-18.9
Depreciation & Amortization
0.410.280.150.14
Stock-Based Compensation
5.391.930.250.12
Provision & Write-off of Bad Debts
1.220.410.370.87
Other Operating Activities
3.042.932.11.19
Change in Accounts Receivable
-5.28-5.01-3.97-2.43
Change in Inventory
-3.32-2.69-1.8-0.91
Change in Accounts Payable
1.462.320.30.94
Change in Other Net Operating Assets
-0.630.491.391.51
Operating Cash Flow
-34.15-28.98-25.47-17.48
Operating Cash Flow Growth
----

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Capital Expenditures
-0.43-0.64-0.18-0.14
Sale (Purchase) of Intangibles
-1.1-0.72--
Investment in Securities
-42.91-24--
Other Investing Activities
--0.13--
Investing Cash Flow
-44.44-25.48-0.18-0.14

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Long-Term Debt Issued
--6.213.13
Net Debt Issued (Repaid)
--6.213.13
Issuance of Common Stock
94.1793.670.030.06
Other Financing Activities
-2.81-5.46--
Financing Cash Flow
91.35100.1358.53.18

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Net Cash Flow
12.7745.6732.85-14.44

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Free Cash Flow
-34.58-29.62-25.65-17.62
Free Cash Flow Growth
----
Free Cash Flow Margin
-54.63%-58.64%-94.41%-127.85%
Free Cash Flow Per Share
-1.36-2.08-6.31-4.53
Levered Free Cash Flow
-26.41-21.65-17.29-
Unlevered Free Cash Flow
-25.57-20.75-16.46-

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23
Cash Interest Paid
1.21.21.120.52
Change in Working Capital
-7.77-4.89-4.08-0.89
SEC Filings: 10-K · 10-Q